Hospital Outbreak of Fluconazole-Resistant Candida parapsilosis: Arguments for Clonal Transmission and Long-Term Persistence
- 19 April 2021
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (5)
- https://doi.org/10.1128/aac.02036-20
Abstract
The worldwide emergence of multidrug-resistant pathogenic fungi is a threat to human health. At this very moment, an emergence of Candida parapsilosis isolates harbouring a resistance to fluconazole, one of the most popular antifungal drugs, is being described in several countries. We seek to better understanding the epidemiology, pathogenicity and transmission of resistant Candida parapsilosis. Faced with an outbreak of invasive infections due to resistant isolates of C. parapsilosis, we performed a 7-year retrospective and prospective analysis of 283 C. parapsilosis isolates collected in 240 patients, among who 111 had invasive candidiasis. Study included review of hospital records, genotyping analysis and susceptibility testing that allow determining the type and outcome of infections, as well as the spatial and temporal spread of clusters. Overall the incidence of azole resistance was 7.5%. Genotyping analysis unveiled several previously undetected outbreaks and clonal spread of susceptible and resistant isolates over a long period of time. In comparison with susceptible isolates, resistant ones have a more restricted genetic diversity and seem to be more likely to spread and more frequently associated with invasive infections. In intensive care units, patients with invasive infections due to resistant isolates had poorer outcome (overall mortality at day 30 of 40%; 4/10) than susceptible ones (overall mortality at day 30 of 26.5%; 9/34). Our results suggest that the propensity of C. parapsilosis to spread on an epidemic fashion is underestimated, which warrants reinforced control and epidemiological survey of this species.Keywords
This publication has 24 references indexed in Scilit:
- Emergence of azole-resistantCandida parapsilosiscausing bloodstream infection: results from laboratory-based sentinel surveillance in South AfricaJournal of Antimicrobial Chemotherapy, 2016
- Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from IndiaMycoses, 2015
- Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance SystemAntimicrobial Agents and Chemotherapy, 2015
- Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicansAntimicrobial Agents and Chemotherapy, 2015
- Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in SpainClinical Microbiology & Infection, 2014
- Microsatellite Genotyping Clarified Conspicuous Accumulation of Candida parapsilosis at a Cardiothoracic Surgery Intensive Care UnitJournal of Clinical Microbiology, 2012
- Invasive fungal infections following liver transplantation: Incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007)Liver Transplantation, 2012
- Outbreak of Candida parapsilosis in a neonatal intensive care unit: a health care workers sourceEuropean Journal of Pediatrics, 2009
- Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis : a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005Journal of Clinical Microbiology, 2008
- An outbreak of Candida parapsilosis prosthetic valve endocarditis following cardiac surgeryJournal of Hospital Infection, 1994